We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
203 hedge funds and large institutions have $3.34B invested in Acadia Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 86 increasing their positions, 64 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
34% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 64
0.32% less ownership
Funds ownership: 98.47% → 98.15% (-0.32%)
7% less funds holding
Funds holding: 219 → 203 (-16)
19% less capital invested
Capital invested by funds: $4.11B → $3.34B (-$770M)
27% less call options, than puts
Call options by funds: $29.6M | Put options by funds: $40.6M
40% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 35
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
203
Holders Change
-16
Holders Change %
-7.31%
% of All Funds
5.06%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.05%
New
21
Increased
86
Reduced
64
Closed
35
Calls
$29.6M
Puts
$40.6M
Net Calls
-$11M
Net Calls Change
+$5.65M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$109M |
| 2 |
Goldman Sachs
New York
|
+$23.4M |
| 3 |
Millennium Management
New York
|
+$16.4M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$15.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$15.2M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$40.2M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$33.7M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$30.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15.7M |
| 5 |
JP
Jana Partners
New York
|
-$14.5M |
